Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D) - Top-Institutions - MDSpire

Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D)

  • By

  • Patrick Ingiliz

  • Erwan Vo-Quang

  • Gibril Ndow

  • Maud Lemoine

  • Amie Ceesay

  • Sainabou Drammeh

  • Marie-Noëlle Hilleret

  • Laure Bordy

  • Thomas Decaens

  • Anne-Laure Mazialivoua

  • Yusuke Shimakawa

  • Alhagie B Touray

  • Jean-Michel Pawlotsky

  • Isabelle Chemin

  • Stephane Chevaliez

  • Vincent Leroy

  • December 26, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Institut Pasteur
    Institut Pasteur

    Paris, Île-de-France

    Key Differentiators

    • Hepatology
    • Virology
    • Infectious Diseases
    • Global Health

  • #2

    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, Maryland

    Key Differentiators

    • Infectious Diseases
    • Hepatology
    • Virology
    • Immunology

  • #3

    University of Oxford - Nuffield Department of Medicine
    University of Oxford - Nuffield Department of Medicine

    Oxford, Oxfordshire

    Key Differentiators

    • Hepatology
    • Infectious Diseases
    • Epidemiology

  • #4

    Karolinska Institutet
    Karolinska Institutet

    Stockholm, Stockholm County

    Key Differentiators

    • Hepatology
    • Virology
    • Global Health

  • #5

    University of California, San Francisco (UCSF) - Liver Center
    University of California, San Francisco (UCSF) - Liver Center

    San Francisco, California

    Key Differentiators

    • Hepatology
    • Infectious Diseases
    • Clinical Research

Original Source(s)

Hepatitis D Virus Seroconversion Rate Among People With Chronic Hepatitis B Virus Infection in France and The Gambia (Inci-D)

  • by Patrick Ingiliz, Erwan Vo-Quang, Gibril Ndow, Maud Lemoine, Amie Ceesay, Sainabou Drammeh, Marie-Noëlle Hilleret, Laure Bordy, Thomas Decaens, Anne-Laure Mazialivoua, Yusuke Shimakawa, Alhagie B Touray, Jean-Michel Pawlotsky, Isabelle Chemin, Stephane Chevaliez, Vincent Leroy

  • December 26, 2025

Related Content

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Graft weight integration in the early allograft dysfunction formula improves the prediction of early graft loss after liver transplantation

Hepatitis B Core-Related Antigen Point-of-Care Tests as a Risk Stratification Tool for Treatment Eligibility: Experience From Kenya